Business Of Biotech

The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by Bioprocess Online and Life Science Connect and brought to you by Cytiva.

Follow on

Episodes

004: Finding Funding In Volatile Times With Dr. Ben Zeskind

We love to hear from our listeners. Send us a message. This week's Business Of Biotech pod features Immuneering CEO Dr. Ben Zeskind, who launched his biotech on the back of creative financing in the throes of the Great Recession. A pivot into biopharma landed Immuneering a $20 million series A round to develop its pipeline--at the outset of the COVID-19 pandemic. Dr. Zeskind joins us for a candid and instructive discussion on getting creative when the economy isn't exactly booming. Acc...

Jun 01, 2020•36 min

003: Building The Biopharma Pitch With Leslie Williams

We love to hear from our listeners. Send us a message. Leslie Williams is a multi-time biotech founder and board member who's honed her pitch-building skills to a fine point. On this episode of The Business Of Biotech, Williams shares best practices for building your pitch deck, how to draw out the nuance that makes your story unique, what to expect in your initial pitch session and follow-on meetings, and why the human element trumps everything else in an otherwise formulaic pitch process....

May 18, 2020•45 min

002: The Biopharma Exit Strategy With Dr. Francois Nader

We love to hear from our listeners. Send us a message. Every emerging biopharma company shares a common goal: creating value for its employees, its board, its investors, and ultimately, patients. Along the way, that value creation might get a boost from an IPO, a merger, an acquisition, or steady growth as a private entity. On this episode of The Business Of Biotech, we talk with Dr. Francois Nader —a man who's orchestrated several wildly successful biotech exits—about why it's imperat...

May 04, 2020•36 min

001: The Business Of Biotech: Allan Shaw

We love to hear from our listeners. Send us a message. There are few better suited to advise the leaders of new and emerging biopharma companies on the building blocks of a biotech startup than Allan Shaw . That's why we chose Shaw to help us kick off our Business of Biotech podcast series with an overview of the episodes to come. In addition to his work on the financial front lines of several biotechs, Shaw holds multiple board of director roles with startup biopharma firms, and he advises...

Apr 20, 2020•39 min

Business Of Biotech Trailer

We love to hear from our listeners. Send us a message. Produced by BioProcess Online, the Business Of Biotech serves as a resource for the leaders of new and emerging biopharmas. We've lined up an incredible group of guests to join us—all of them founders who have taken biotherapy ideas and successfully turned them into clinical realities. Here’s a preview of how the series, which is focused on the financial, organizational, HR, and regulatory aspects of launching a biopharma company, will ...

Apr 14, 2020•5 min

← Prev